Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thyroidectomy | 149 | 2024 | 879 | 23.460 |
Why?
|
Thyroid Neoplasms | 137 | 2024 | 2282 | 17.700 |
Why?
|
Recurrent Laryngeal Nerve | 52 | 2022 | 139 | 12.360 |
Why?
|
Monitoring, Intraoperative | 57 | 2021 | 957 | 11.030 |
Why?
|
Vocal Cord Paralysis | 43 | 2022 | 267 | 10.010 |
Why?
|
Thyroid Gland | 60 | 2023 | 1173 | 8.570 |
Why?
|
Thyroid Nodule | 37 | 2023 | 750 | 7.030 |
Why?
|
Electromyography | 49 | 2022 | 1379 | 6.780 |
Why?
|
Carcinoma, Papillary | 31 | 2024 | 783 | 5.240 |
Why?
|
Laryngeal Nerves | 18 | 2021 | 56 | 5.220 |
Why?
|
Parathyroidectomy | 25 | 2022 | 235 | 5.080 |
Why?
|
Parathyroid Glands | 23 | 2023 | 509 | 4.720 |
Why?
|
Otolaryngology | 24 | 2021 | 645 | 4.410 |
Why?
|
Adenocarcinoma, Follicular | 13 | 2024 | 324 | 4.100 |
Why?
|
Neck Dissection | 22 | 2024 | 197 | 3.900 |
Why?
|
Vagus Nerve | 18 | 2021 | 438 | 3.550 |
Why?
|
Carcinoma | 17 | 2023 | 2375 | 2.730 |
Why?
|
Thyroid Diseases | 15 | 2020 | 379 | 2.600 |
Why?
|
Endocrine Surgical Procedures | 6 | 2023 | 33 | 2.540 |
Why?
|
Intraoperative Complications | 17 | 2020 | 1198 | 2.500 |
Why?
|
Hypoparathyroidism | 6 | 2023 | 120 | 2.470 |
Why?
|
Laryngeal Muscles | 10 | 2021 | 98 | 2.360 |
Why?
|
Neck | 14 | 2022 | 698 | 2.350 |
Why?
|
Larynx | 12 | 2021 | 494 | 2.110 |
Why?
|
Electric Stimulation | 7 | 2021 | 1767 | 2.000 |
Why?
|
Carcinoma, Papillary, Follicular | 5 | 2020 | 60 | 1.910 |
Why?
|
Goiter | 5 | 2019 | 87 | 1.770 |
Why?
|
Carcinoma, Neuroendocrine | 8 | 2024 | 332 | 1.740 |
Why?
|
Laryngoscopy | 16 | 2022 | 710 | 1.720 |
Why?
|
Biopsy, Fine-Needle | 24 | 2022 | 1094 | 1.720 |
Why?
|
Endocrinology | 10 | 2021 | 443 | 1.690 |
Why?
|
Iodine Radioisotopes | 15 | 2024 | 1032 | 1.590 |
Why?
|
Voice Disorders | 5 | 2021 | 276 | 1.560 |
Why?
|
Postoperative Complications | 34 | 2022 | 15295 | 1.430 |
Why?
|
Voice Quality | 4 | 2021 | 217 | 1.380 |
Why?
|
Lymphatic Metastasis | 23 | 2024 | 2924 | 1.370 |
Why?
|
Evidence-Based Medicine | 17 | 2023 | 3610 | 1.360 |
Why?
|
Hyperparathyroidism, Primary | 5 | 2021 | 160 | 1.170 |
Why?
|
Consensus | 16 | 2022 | 2960 | 1.160 |
Why?
|
Humans | 298 | 2024 | 744376 | 1.150 |
Why?
|
Thyroglobulin | 4 | 2015 | 114 | 1.140 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 5 | 2021 | 312 | 1.100 |
Why?
|
Reoperation | 12 | 2023 | 4201 | 1.090 |
Why?
|
Practice Guidelines as Topic | 17 | 2021 | 7281 | 1.070 |
Why?
|
Cost-Benefit Analysis | 12 | 2022 | 5390 | 1.060 |
Why?
|
Preoperative Care | 14 | 2021 | 2250 | 1.010 |
Why?
|
Calcitonin | 7 | 2020 | 336 | 0.990 |
Why?
|
Lymph Nodes | 13 | 2024 | 3475 | 0.960 |
Why?
|
Otorhinolaryngologic Diseases | 4 | 2019 | 90 | 0.960 |
Why?
|
Neoplasm Invasiveness | 15 | 2021 | 3616 | 0.940 |
Why?
|
Parathyroid Neoplasms | 7 | 2021 | 245 | 0.940 |
Why?
|
Robotics | 4 | 2023 | 899 | 0.930 |
Why?
|
Electrodes | 5 | 2021 | 619 | 0.930 |
Why?
|
Parathyroid Diseases | 4 | 2020 | 48 | 0.910 |
Why?
|
Electrodiagnosis | 2 | 2014 | 151 | 0.900 |
Why?
|
Adenoma, Oxyphilic | 2 | 2024 | 143 | 0.900 |
Why?
|
Ultrasonography | 17 | 2021 | 5984 | 0.810 |
Why?
|
Cranial Nerve Injuries | 1 | 2021 | 25 | 0.810 |
Why?
|
Fellowships and Scholarships | 3 | 2020 | 1078 | 0.800 |
Why?
|
Neoplasm Recurrence, Local | 18 | 2023 | 9240 | 0.790 |
Why?
|
Intubation, Intratracheal | 6 | 2020 | 1364 | 0.770 |
Why?
|
Retrospective Studies | 67 | 2024 | 77459 | 0.770 |
Why?
|
Cranial Nerves | 1 | 2021 | 101 | 0.760 |
Why?
|
Tracheal Diseases | 1 | 2021 | 113 | 0.750 |
Why?
|
Neoplasm Staging | 14 | 2018 | 11031 | 0.730 |
Why?
|
Head | 3 | 2021 | 880 | 0.730 |
Why?
|
Vagus Nerve Stimulation | 6 | 2019 | 199 | 0.720 |
Why?
|
Oxyphil Cells | 1 | 2020 | 57 | 0.710 |
Why?
|
Choristoma | 1 | 2021 | 214 | 0.690 |
Why?
|
Surgical Sponges | 1 | 2019 | 46 | 0.680 |
Why?
|
Intraoperative Care | 3 | 2020 | 767 | 0.670 |
Why?
|
Physicians' Offices | 1 | 2019 | 58 | 0.670 |
Why?
|
Societies, Medical | 11 | 2019 | 3743 | 0.660 |
Why?
|
Societies | 1 | 2018 | 104 | 0.630 |
Why?
|
Iatrogenic Disease | 2 | 2019 | 547 | 0.630 |
Why?
|
Middle Aged | 85 | 2023 | 213388 | 0.630 |
Why?
|
Models, Educational | 1 | 2020 | 377 | 0.610 |
Why?
|
Male | 105 | 2023 | 350118 | 0.610 |
Why?
|
Nuclear Medicine | 1 | 2020 | 233 | 0.600 |
Why?
|
Female | 118 | 2023 | 380200 | 0.590 |
Why?
|
Aged | 65 | 2023 | 163284 | 0.590 |
Why?
|
Adult | 79 | 2024 | 214056 | 0.580 |
Why?
|
Thyroglossal Cyst | 1 | 2015 | 31 | 0.540 |
Why?
|
Interdisciplinary Communication | 6 | 2018 | 950 | 0.540 |
Why?
|
Glottis | 3 | 2015 | 217 | 0.520 |
Why?
|
Analgesics, Opioid | 3 | 2021 | 3677 | 0.510 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 547 | 0.510 |
Why?
|
Terminology as Topic | 4 | 2016 | 1547 | 0.510 |
Why?
|
Pain, Postoperative | 3 | 2023 | 1643 | 0.500 |
Why?
|
Serial Publications | 1 | 2014 | 10 | 0.500 |
Why?
|
Catheter Ablation | 4 | 2023 | 2758 | 0.500 |
Why?
|
Electrophysiological Phenomena | 5 | 2016 | 315 | 0.500 |
Why?
|
Foreign Bodies | 1 | 2019 | 400 | 0.500 |
Why?
|
Carcinoma, Medullary | 5 | 2011 | 123 | 0.500 |
Why?
|
Foreign-Body Migration | 1 | 2016 | 222 | 0.490 |
Why?
|
Investments | 1 | 2016 | 143 | 0.490 |
Why?
|
Prospective Studies | 30 | 2024 | 53291 | 0.480 |
Why?
|
United States | 35 | 2023 | 69869 | 0.480 |
Why?
|
Ophthalmology | 1 | 2020 | 508 | 0.480 |
Why?
|
Workflow | 1 | 2018 | 847 | 0.470 |
Why?
|
Quality Improvement | 3 | 2018 | 3749 | 0.470 |
Why?
|
Carcinoid Tumor | 1 | 2015 | 235 | 0.460 |
Why?
|
Prognosis | 22 | 2023 | 29060 | 0.440 |
Why?
|
Occupations | 1 | 2015 | 517 | 0.430 |
Why?
|
Intestinal Neoplasms | 1 | 2015 | 319 | 0.430 |
Why?
|
Preoperative Period | 5 | 2020 | 549 | 0.430 |
Why?
|
Internationality | 4 | 2021 | 1002 | 0.430 |
Why?
|
Hypoglossal Nerve | 3 | 2020 | 95 | 0.430 |
Why?
|
Neuromuscular Blockade | 3 | 2020 | 146 | 0.420 |
Why?
|
Aged, 80 and over | 28 | 2023 | 57776 | 0.410 |
Why?
|
Indocyanine Green | 2 | 2023 | 239 | 0.400 |
Why?
|
Minocycline | 1 | 2012 | 163 | 0.400 |
Why?
|
Medical Oncology | 4 | 2022 | 2267 | 0.400 |
Why?
|
Monitoring, Physiologic | 3 | 2015 | 1739 | 0.390 |
Why?
|
Delphi Technique | 3 | 2021 | 779 | 0.390 |
Why?
|
Hyperpigmentation | 1 | 2012 | 112 | 0.390 |
Why?
|
Ultrasonography, Interventional | 3 | 2021 | 1486 | 0.390 |
Why?
|
Feedback | 2 | 2017 | 795 | 0.380 |
Why?
|
Lymph Node Excision | 6 | 2017 | 1261 | 0.380 |
Why?
|
Young Adult | 24 | 2024 | 56434 | 0.370 |
Why?
|
Vocal Cords | 5 | 2018 | 528 | 0.370 |
Why?
|
Diagnostic Tests, Routine | 2 | 2013 | 783 | 0.370 |
Why?
|
Endoscopy | 4 | 2022 | 1787 | 0.360 |
Why?
|
Graves Disease | 2 | 2022 | 242 | 0.360 |
Why?
|
Incidental Findings | 1 | 2015 | 689 | 0.360 |
Why?
|
Equipment Design | 4 | 2021 | 3582 | 0.350 |
Why?
|
Treatment Outcome | 26 | 2023 | 63115 | 0.340 |
Why?
|
Swine | 15 | 2022 | 5918 | 0.340 |
Why?
|
Neuroendocrine Tumors | 1 | 2015 | 594 | 0.340 |
Why?
|
Algorithms | 9 | 2023 | 13882 | 0.330 |
Why?
|
Intestine, Small | 1 | 2015 | 1240 | 0.330 |
Why?
|
Postoperative Period | 6 | 2021 | 1842 | 0.320 |
Why?
|
Respiration | 1 | 2015 | 1653 | 0.310 |
Why?
|
Dogs | 6 | 2016 | 3912 | 0.310 |
Why?
|
Quality of Life | 7 | 2023 | 12803 | 0.310 |
Why?
|
Diagnosis, Differential | 11 | 2019 | 12961 | 0.300 |
Why?
|
Radiology | 1 | 2021 | 2099 | 0.300 |
Why?
|
Program Evaluation | 1 | 2016 | 2488 | 0.300 |
Why?
|
Four-Dimensional Computed Tomography | 3 | 2020 | 145 | 0.290 |
Why?
|
Sensitivity and Specificity | 9 | 2023 | 14723 | 0.290 |
Why?
|
Disease Management | 2 | 2020 | 2460 | 0.290 |
Why?
|
Diagnostic Imaging | 5 | 2021 | 3508 | 0.280 |
Why?
|
Adolescent | 29 | 2023 | 85784 | 0.280 |
Why?
|
Palpation | 3 | 2008 | 167 | 0.280 |
Why?
|
Anesthesiology | 2 | 2016 | 1060 | 0.280 |
Why?
|
Decision Making | 7 | 2018 | 3888 | 0.280 |
Why?
|
Cytodiagnosis | 2 | 2020 | 435 | 0.280 |
Why?
|
Internship and Residency | 3 | 2022 | 5789 | 0.280 |
Why?
|
Models, Animal | 8 | 2019 | 2173 | 0.280 |
Why?
|
Guideline Adherence | 3 | 2016 | 2265 | 0.280 |
Why?
|
Head and Neck Neoplasms | 5 | 2022 | 2736 | 0.280 |
Why?
|
Pediatrics | 3 | 2020 | 3475 | 0.270 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2010 | 454 | 0.270 |
Why?
|
Trachea | 3 | 2021 | 1076 | 0.270 |
Why?
|
Models, Organizational | 1 | 2009 | 574 | 0.270 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2014 | 2943 | 0.260 |
Why?
|
Reaction Time | 3 | 2016 | 2098 | 0.250 |
Why?
|
Follow-Up Studies | 15 | 2019 | 39052 | 0.250 |
Why?
|
Genetic Testing | 1 | 2017 | 3444 | 0.240 |
Why?
|
Private Practice | 1 | 2005 | 154 | 0.240 |
Why?
|
Delivery of Health Care | 6 | 2022 | 5321 | 0.240 |
Why?
|
Recovery of Function | 2 | 2017 | 2926 | 0.240 |
Why?
|
Child | 19 | 2023 | 77708 | 0.240 |
Why?
|
Decision Support Techniques | 4 | 2020 | 1956 | 0.230 |
Why?
|
Predictive Value of Tests | 10 | 2018 | 15078 | 0.230 |
Why?
|
Probability | 3 | 2014 | 2506 | 0.230 |
Why?
|
Tomography, X-Ray Computed | 15 | 2023 | 20130 | 0.230 |
Why?
|
Voice | 3 | 2015 | 259 | 0.220 |
Why?
|
Cervical Plexus | 2 | 2020 | 12 | 0.220 |
Why?
|
Thyroiditis | 1 | 2023 | 85 | 0.220 |
Why?
|
Public Health | 1 | 2016 | 2602 | 0.220 |
Why?
|
Hypocalcemia | 2 | 2014 | 191 | 0.210 |
Why?
|
Databases, Factual | 7 | 2019 | 7730 | 0.210 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2020 | 1771 | 0.210 |
Why?
|
Axilla | 2 | 2022 | 595 | 0.210 |
Why?
|
Family Practice | 1 | 2005 | 516 | 0.210 |
Why?
|
Republic of Korea | 2 | 2021 | 538 | 0.210 |
Why?
|
Hashimoto Disease | 1 | 2023 | 98 | 0.210 |
Why?
|
Hypercalcemia | 2 | 2021 | 409 | 0.210 |
Why?
|
Proto-Oncogene Proteins B-raf | 4 | 2023 | 2043 | 0.210 |
Why?
|
Postoperative Care | 3 | 2018 | 1487 | 0.200 |
Why?
|
Cricoid Cartilage | 1 | 2021 | 72 | 0.200 |
Why?
|
Parathyroid Hormone | 5 | 2021 | 1800 | 0.200 |
Why?
|
Goiter, Substernal | 2 | 2011 | 17 | 0.200 |
Why?
|
Thyroid Function Tests | 1 | 2022 | 286 | 0.200 |
Why?
|
Tomography, Optical Coherence | 1 | 2013 | 2657 | 0.190 |
Why?
|
Anastomosis, Surgical | 2 | 2021 | 987 | 0.190 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2021 | 170 | 0.190 |
Why?
|
North Carolina | 2 | 2016 | 315 | 0.190 |
Why?
|
Equipment Safety | 2 | 2019 | 263 | 0.190 |
Why?
|
Markov Chains | 3 | 2020 | 969 | 0.190 |
Why?
|
Latin America | 1 | 2021 | 380 | 0.190 |
Why?
|
Tumor Burden | 3 | 2016 | 1915 | 0.190 |
Why?
|
Risk Assessment | 10 | 2020 | 23336 | 0.180 |
Why?
|
Reproducibility of Results | 10 | 2022 | 19905 | 0.180 |
Why?
|
Hospitals, Pediatric | 1 | 2009 | 1775 | 0.180 |
Why?
|
Medical Errors | 2 | 2019 | 1297 | 0.180 |
Why?
|
Patient Positioning | 2 | 2020 | 324 | 0.180 |
Why?
|
Preventive Health Services | 1 | 2005 | 575 | 0.180 |
Why?
|
Survival Analysis | 5 | 2018 | 10252 | 0.180 |
Why?
|
Quality-Adjusted Life Years | 4 | 2020 | 1683 | 0.180 |
Why?
|
Jugular Veins | 1 | 2021 | 204 | 0.180 |
Why?
|
Bell Palsy | 1 | 2020 | 41 | 0.180 |
Why?
|
Kazakhstan | 1 | 2019 | 14 | 0.170 |
Why?
|
gamma-Cyclodextrins | 2 | 2016 | 17 | 0.170 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2021 | 602 | 0.170 |
Why?
|
Androstanols | 2 | 2016 | 47 | 0.170 |
Why?
|
Paranasal Sinus Diseases | 1 | 2000 | 116 | 0.170 |
Why?
|
Vascular Neoplasms | 1 | 2021 | 175 | 0.170 |
Why?
|
Hemostasis, Surgical | 1 | 2019 | 128 | 0.170 |
Why?
|
Salivary Glands | 1 | 2020 | 229 | 0.170 |
Why?
|
Gallstones | 1 | 2021 | 286 | 0.170 |
Why?
|
Quality Indicators, Health Care | 1 | 2009 | 1831 | 0.170 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 2019 | 126 | 0.170 |
Why?
|
Wound Closure Techniques | 1 | 2019 | 83 | 0.160 |
Why?
|
Quality Assurance, Health Care | 1 | 2009 | 2212 | 0.160 |
Why?
|
District of Columbia | 1 | 2018 | 157 | 0.160 |
Why?
|
Optics and Photonics | 1 | 2000 | 321 | 0.160 |
Why?
|
Spectrometry, Fluorescence | 1 | 2020 | 688 | 0.160 |
Why?
|
Medical Illustration | 1 | 2019 | 133 | 0.160 |
Why?
|
Laryngoscopes | 1 | 2020 | 148 | 0.160 |
Why?
|
Neuromuscular Nondepolarizing Agents | 2 | 2016 | 146 | 0.160 |
Why?
|
Laryngectomy | 2 | 2014 | 248 | 0.160 |
Why?
|
Clinical Competence | 5 | 2021 | 4687 | 0.160 |
Why?
|
Risk | 4 | 2020 | 9688 | 0.160 |
Why?
|
Cross-Sectional Studies | 14 | 2023 | 25041 | 0.160 |
Why?
|
Organ Preservation | 1 | 2020 | 331 | 0.160 |
Why?
|
Patient Selection | 3 | 2020 | 4216 | 0.150 |
Why?
|
Cholecystectomy | 2 | 2021 | 395 | 0.150 |
Why?
|
Brachial Plexus Neuropathies | 1 | 2019 | 122 | 0.150 |
Why?
|
Thyroid Cartilage | 1 | 2017 | 42 | 0.150 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 2019 | 243 | 0.150 |
Why?
|
Pancreatic Neoplasms | 1 | 2015 | 5263 | 0.150 |
Why?
|
Gastrins | 1 | 2017 | 81 | 0.150 |
Why?
|
Hematologic Tests | 1 | 2018 | 240 | 0.150 |
Why?
|
Specialties, Surgical | 1 | 2022 | 391 | 0.150 |
Why?
|
Mass Screening | 3 | 2020 | 5255 | 0.150 |
Why?
|
Cell Differentiation | 6 | 2017 | 11486 | 0.140 |
Why?
|
Contrast Media | 5 | 2020 | 5300 | 0.140 |
Why?
|
Gastric Acid | 1 | 2017 | 104 | 0.140 |
Why?
|
Natural Orifice Endoscopic Surgery | 1 | 2018 | 118 | 0.140 |
Why?
|
Animals | 23 | 2022 | 168770 | 0.140 |
Why?
|
Nerve Block | 1 | 2023 | 644 | 0.140 |
Why?
|
Gene Fusion | 1 | 2019 | 371 | 0.140 |
Why?
|
Patient Care Team | 3 | 2018 | 2531 | 0.140 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2014 | 1534 | 0.140 |
Why?
|
Hematoma | 2 | 2019 | 758 | 0.140 |
Why?
|
Stroboscopy | 1 | 2016 | 64 | 0.140 |
Why?
|
Lymphoma | 2 | 2022 | 1877 | 0.140 |
Why?
|
Technetium Tc 99m Sestamibi | 3 | 2019 | 177 | 0.140 |
Why?
|
Endocrine Gland Neoplasms | 1 | 2015 | 25 | 0.140 |
Why?
|
Facial Paralysis | 1 | 2020 | 338 | 0.130 |
Why?
|
Esophagus | 2 | 2014 | 1019 | 0.130 |
Why?
|
Electronic Health Records | 3 | 2018 | 4468 | 0.130 |
Why?
|
Multiple Endocrine Neoplasia | 1 | 2015 | 25 | 0.130 |
Why?
|
Leadership | 2 | 2019 | 1357 | 0.130 |
Why?
|
Carcinoid Heart Disease | 1 | 2015 | 10 | 0.130 |
Why?
|
Incidence | 7 | 2022 | 20950 | 0.130 |
Why?
|
Pancreatic Polypeptide | 1 | 2015 | 34 | 0.130 |
Why?
|
RNA, Neoplasm | 1 | 2018 | 769 | 0.130 |
Why?
|
Chromogranin A | 1 | 2015 | 54 | 0.130 |
Why?
|
Gene Expression Profiling | 3 | 2022 | 9445 | 0.130 |
Why?
|
Education, Medical, Continuing | 2 | 2011 | 840 | 0.130 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2020 | 721 | 0.130 |
Why?
|
Flushing | 1 | 2015 | 49 | 0.130 |
Why?
|
North America | 1 | 2018 | 1249 | 0.130 |
Why?
|
Informed Consent | 1 | 2021 | 995 | 0.130 |
Why?
|
Prosthesis Implantation | 1 | 2020 | 642 | 0.130 |
Why?
|
Denervation | 1 | 2016 | 278 | 0.130 |
Why?
|
Perioperative Care | 2 | 2013 | 1002 | 0.130 |
Why?
|
Documentation | 1 | 2021 | 871 | 0.130 |
Why?
|
Granuloma, Foreign-Body | 1 | 1995 | 45 | 0.130 |
Why?
|
Risk Factors | 13 | 2024 | 72295 | 0.130 |
Why?
|
Dissection | 1 | 2016 | 295 | 0.120 |
Why?
|
Octreotide | 1 | 2015 | 145 | 0.120 |
Why?
|
Cohort Studies | 8 | 2022 | 40558 | 0.120 |
Why?
|
Recurrence | 4 | 2018 | 8340 | 0.120 |
Why?
|
Medical History Taking | 1 | 2018 | 784 | 0.120 |
Why?
|
Cross-Over Studies | 1 | 2020 | 2029 | 0.120 |
Why?
|
Mesentery | 1 | 2015 | 205 | 0.120 |
Why?
|
General Surgery | 2 | 2019 | 1636 | 0.120 |
Why?
|
Polytetrafluoroethylene | 1 | 1995 | 233 | 0.120 |
Why?
|
Electric Stimulation Therapy | 1 | 2020 | 605 | 0.120 |
Why?
|
Risk Management | 1 | 2018 | 571 | 0.120 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2016 | 161 | 0.120 |
Why?
|
Decision Trees | 3 | 2020 | 506 | 0.120 |
Why?
|
Medicare | 3 | 2023 | 6566 | 0.120 |
Why?
|
International Classification of Diseases | 1 | 2019 | 867 | 0.120 |
Why?
|
Surgical Instruments | 1 | 2016 | 395 | 0.120 |
Why?
|
Tracheotomy | 1 | 2014 | 166 | 0.120 |
Why?
|
Cholecalciferol | 1 | 2018 | 535 | 0.110 |
Why?
|
Branchial Region | 2 | 2010 | 35 | 0.110 |
Why?
|
Interinstitutional Relations | 1 | 2014 | 241 | 0.110 |
Why?
|
Patient Preference | 1 | 2020 | 889 | 0.110 |
Why?
|
Frozen Sections | 1 | 2013 | 155 | 0.110 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2017 | 604 | 0.110 |
Why?
|
Somatostatin | 1 | 2015 | 459 | 0.110 |
Why?
|
Tongue | 1 | 2016 | 406 | 0.110 |
Why?
|
Medical Record Linkage | 1 | 2014 | 284 | 0.110 |
Why?
|
Ki-67 Antigen | 1 | 2015 | 644 | 0.110 |
Why?
|
Registries | 2 | 2021 | 8091 | 0.110 |
Why?
|
Liver Neoplasms | 2 | 2021 | 4253 | 0.110 |
Why?
|
Peptides, Cyclic | 1 | 2015 | 400 | 0.110 |
Why?
|
ras Proteins | 1 | 2018 | 1060 | 0.110 |
Why?
|
Neurosurgical Procedures | 2 | 2020 | 2002 | 0.110 |
Why?
|
RNA | 1 | 2022 | 2749 | 0.100 |
Why?
|
Monte Carlo Method | 1 | 2017 | 1254 | 0.100 |
Why?
|
Video-Assisted Surgery | 1 | 2012 | 51 | 0.100 |
Why?
|
Safety Management | 1 | 2018 | 783 | 0.100 |
Why?
|
Hypothyroidism | 1 | 2017 | 658 | 0.100 |
Why?
|
Radionuclide Imaging | 2 | 2014 | 2031 | 0.100 |
Why?
|
Self Efficacy | 1 | 2016 | 616 | 0.100 |
Why?
|
Qualitative Research | 1 | 2020 | 2682 | 0.100 |
Why?
|
Specialization | 1 | 2016 | 776 | 0.100 |
Why?
|
Random Allocation | 1 | 2016 | 2428 | 0.100 |
Why?
|
Venous Thrombosis | 1 | 2021 | 1239 | 0.100 |
Why?
|
Access to Information | 1 | 2014 | 320 | 0.100 |
Why?
|
Anesthesia | 2 | 2021 | 1560 | 0.100 |
Why?
|
Hospitals, University | 1 | 2013 | 570 | 0.100 |
Why?
|
Faculty, Medical | 1 | 2019 | 1181 | 0.100 |
Why?
|
Gene Rearrangement | 1 | 2016 | 1179 | 0.090 |
Why?
|
Esophagectomy | 1 | 2014 | 447 | 0.090 |
Why?
|
Calcium | 3 | 2021 | 5755 | 0.090 |
Why?
|
Cost Savings | 1 | 2016 | 925 | 0.090 |
Why?
|
Peripheral Nervous System | 1 | 2011 | 150 | 0.090 |
Why?
|
Transplantation, Autologous | 1 | 2015 | 2124 | 0.090 |
Why?
|
Vitamins | 1 | 2018 | 1623 | 0.090 |
Why?
|
Prevalence | 4 | 2019 | 15221 | 0.090 |
Why?
|
Body Weight | 1 | 2020 | 4671 | 0.090 |
Why?
|
False Positive Reactions | 2 | 2009 | 980 | 0.090 |
Why?
|
Immunohistochemistry | 2 | 2014 | 11366 | 0.090 |
Why?
|
Radiotherapy Dosage | 1 | 2015 | 2879 | 0.080 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2021 | 2214 | 0.080 |
Why?
|
Organ Transplantation | 1 | 2019 | 1140 | 0.080 |
Why?
|
Evoked Potentials | 1 | 2015 | 1056 | 0.080 |
Why?
|
Rare Diseases | 1 | 2014 | 553 | 0.080 |
Why?
|
Selection Bias | 1 | 2011 | 371 | 0.080 |
Why?
|
Diarrhea | 2 | 2015 | 1348 | 0.080 |
Why?
|
Neoplasm Metastasis | 3 | 2019 | 4851 | 0.080 |
Why?
|
Primary Prevention | 1 | 2016 | 1167 | 0.080 |
Why?
|
Primary Health Care | 1 | 2005 | 4557 | 0.080 |
Why?
|
Vitamin D Deficiency | 1 | 2018 | 1343 | 0.080 |
Why?
|
Muscles | 1 | 2013 | 1614 | 0.080 |
Why?
|
Review Literature as Topic | 1 | 2011 | 336 | 0.080 |
Why?
|
Preventive Medicine | 1 | 2010 | 264 | 0.080 |
Why?
|
Ethanol | 1 | 2015 | 1342 | 0.080 |
Why?
|
Hyperthyroidism | 1 | 2010 | 295 | 0.080 |
Why?
|
Feasibility Studies | 3 | 2018 | 5077 | 0.080 |
Why?
|
Abdominal Pain | 1 | 2015 | 1064 | 0.080 |
Why?
|
Mutation | 6 | 2023 | 29786 | 0.080 |
Why?
|
Patient Discharge | 1 | 2021 | 3318 | 0.080 |
Why?
|
Chronic Disease | 1 | 2023 | 9145 | 0.080 |
Why?
|
Health Personnel | 1 | 2021 | 3219 | 0.080 |
Why?
|
Adenoma | 2 | 2010 | 2174 | 0.080 |
Why?
|
Prostheses and Implants | 1 | 1995 | 1387 | 0.070 |
Why?
|
Uncertainty | 1 | 2012 | 735 | 0.070 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2020 | 1813 | 0.070 |
Why?
|
Reference Standards | 1 | 2011 | 1025 | 0.070 |
Why?
|
Pilot Projects | 3 | 2015 | 8319 | 0.070 |
Why?
|
Disease Models, Animal | 5 | 2020 | 18034 | 0.070 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2016 | 2455 | 0.070 |
Why?
|
Decision Support Systems, Clinical | 1 | 2016 | 1164 | 0.070 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2887 | 0.070 |
Why?
|
Abscess | 1 | 2010 | 607 | 0.070 |
Why?
|
Organizational Innovation | 1 | 2009 | 559 | 0.070 |
Why?
|
Patient Participation | 1 | 2015 | 1457 | 0.070 |
Why?
|
Airway Obstruction | 1 | 2011 | 664 | 0.070 |
Why?
|
Calcinosis | 1 | 2014 | 1499 | 0.070 |
Why?
|
Bone Density | 1 | 2018 | 3468 | 0.060 |
Why?
|
Survival Rate | 3 | 2021 | 12788 | 0.060 |
Why?
|
Forecasting | 1 | 2014 | 2951 | 0.060 |
Why?
|
Health Status | 1 | 2018 | 4033 | 0.060 |
Why?
|
Morbidity | 1 | 2010 | 1768 | 0.060 |
Why?
|
Population Surveillance | 1 | 2016 | 2616 | 0.060 |
Why?
|
Patient Education as Topic | 1 | 2015 | 2278 | 0.060 |
Why?
|
Deglutition Disorders | 1 | 2011 | 606 | 0.060 |
Why?
|
Speech, Alaryngeal | 1 | 2004 | 32 | 0.060 |
Why?
|
Cartilage | 1 | 2008 | 818 | 0.060 |
Why?
|
Genetic Variation | 1 | 2020 | 6542 | 0.060 |
Why?
|
Biopsy | 4 | 2017 | 6755 | 0.060 |
Why?
|
Infant | 3 | 2021 | 35134 | 0.060 |
Why?
|
Efficiency, Organizational | 1 | 2009 | 695 | 0.060 |
Why?
|
Physicians | 2 | 2016 | 4567 | 0.060 |
Why?
|
Kidney Transplantation | 1 | 2019 | 4251 | 0.060 |
Why?
|
Drainage | 1 | 2010 | 1142 | 0.060 |
Why?
|
Isometric Contraction | 1 | 2004 | 143 | 0.060 |
Why?
|
Neck Muscles | 1 | 2004 | 104 | 0.060 |
Why?
|
Larynx, Artificial | 1 | 2004 | 69 | 0.060 |
Why?
|
Combined Modality Therapy | 2 | 2008 | 8642 | 0.060 |
Why?
|
Sampling Studies | 1 | 2005 | 623 | 0.060 |
Why?
|
Burns | 1 | 2015 | 1815 | 0.060 |
Why?
|
Propensity Score | 2 | 2021 | 1781 | 0.060 |
Why?
|
Biomedical Research | 1 | 2019 | 3309 | 0.060 |
Why?
|
Pyrroles | 1 | 2010 | 1146 | 0.060 |
Why?
|
Suture Techniques | 1 | 2008 | 798 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 1 | 2016 | 4554 | 0.060 |
Why?
|
Radiopharmaceuticals | 2 | 2019 | 2645 | 0.060 |
Why?
|
Reference Values | 1 | 2010 | 4982 | 0.060 |
Why?
|
Radiography | 1 | 2014 | 7023 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2000 | 8949 | 0.060 |
Why?
|
Phonation | 1 | 2004 | 219 | 0.050 |
Why?
|
Lead Poisoning | 1 | 2005 | 301 | 0.050 |
Why?
|
Body Mass Index | 1 | 2020 | 12720 | 0.050 |
Why?
|
Nerve Transfer | 1 | 2004 | 120 | 0.050 |
Why?
|
Early Detection of Cancer | 1 | 2016 | 3086 | 0.050 |
Why?
|
Child, Preschool | 7 | 2023 | 41005 | 0.050 |
Why?
|
Action Potentials | 1 | 2010 | 1806 | 0.050 |
Why?
|
Quality of Health Care | 3 | 2017 | 4369 | 0.050 |
Why?
|
Antithyroid Agents | 1 | 2021 | 70 | 0.050 |
Why?
|
Patient Readmission | 3 | 2022 | 3116 | 0.050 |
Why?
|
Hyperparathyroidism | 2 | 2020 | 339 | 0.050 |
Why?
|
Publishing | 1 | 2009 | 833 | 0.050 |
Why?
|
Indoles | 1 | 2010 | 1839 | 0.050 |
Why?
|
History, 21st Century | 2 | 2021 | 1534 | 0.050 |
Why?
|
Adipose Tissue | 1 | 2013 | 3280 | 0.050 |
Why?
|
Ablation Techniques | 2 | 2015 | 249 | 0.050 |
Why?
|
Matched-Pair Analysis | 1 | 2021 | 288 | 0.050 |
Why?
|
Survivors | 2 | 2023 | 2291 | 0.050 |
Why?
|
Comorbidity | 3 | 2022 | 10388 | 0.050 |
Why?
|
Immunization | 1 | 2005 | 1256 | 0.050 |
Why?
|
ROC Curve | 2 | 2018 | 3527 | 0.050 |
Why?
|
Sex Factors | 3 | 2020 | 10400 | 0.050 |
Why?
|
Healthcare Disparities | 1 | 2015 | 3154 | 0.050 |
Why?
|
Publication Bias | 1 | 2020 | 162 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 4 | 2019 | 35424 | 0.040 |
Why?
|
Proto-Oncogenes | 1 | 2000 | 321 | 0.040 |
Why?
|
Sex Ratio | 1 | 2019 | 110 | 0.040 |
Why?
|
Head Movements | 1 | 2020 | 150 | 0.040 |
Why?
|
Thyrotropin | 2 | 2013 | 849 | 0.040 |
Why?
|
Molecular Probes | 1 | 2020 | 316 | 0.040 |
Why?
|
Abortion, Induced | 2 | 1975 | 458 | 0.040 |
Why?
|
Cultural Diversity | 1 | 2022 | 359 | 0.040 |
Why?
|
DNA Mutational Analysis | 2 | 2018 | 4185 | 0.040 |
Why?
|
Palatine Tonsil | 1 | 1999 | 193 | 0.040 |
Why?
|
Piperidines | 2 | 2019 | 1602 | 0.040 |
Why?
|
Obesity | 1 | 2020 | 12745 | 0.040 |
Why?
|
Carbazoles | 1 | 2019 | 226 | 0.040 |
Why?
|
Neoplasms, Unknown Primary | 1 | 1999 | 104 | 0.040 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 2 | 2015 | 1107 | 0.040 |
Why?
|
Facial Nerve | 1 | 2020 | 271 | 0.040 |
Why?
|
Gastric Acidity Determination | 1 | 2017 | 62 | 0.040 |
Why?
|
Japan | 1 | 2021 | 1360 | 0.040 |
Why?
|
Medically Uninsured | 1 | 2023 | 853 | 0.040 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2006 | 2016 | 0.040 |
Why?
|
Brachial Plexus | 1 | 2019 | 163 | 0.040 |
Why?
|
Thinness | 1 | 2020 | 480 | 0.040 |
Why?
|
Attitude of Health Personnel | 1 | 2011 | 3842 | 0.040 |
Why?
|
Medically Underserved Area | 1 | 2019 | 253 | 0.040 |
Why?
|
Heart Rate, Fetal | 1 | 1997 | 75 | 0.040 |
Why?
|
Medicaid | 2 | 2023 | 2737 | 0.040 |
Why?
|
Guidelines as Topic | 2 | 2014 | 1405 | 0.040 |
Why?
|
Resource Allocation | 1 | 2018 | 341 | 0.030 |
Why?
|
Efficiency | 1 | 2019 | 462 | 0.030 |
Why?
|
Perfusion | 1 | 2020 | 1360 | 0.030 |
Why?
|
Analgesics | 1 | 2023 | 1040 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2020 | 6896 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2022 | 15159 | 0.030 |
Why?
|
Anemia | 1 | 2005 | 1503 | 0.030 |
Why?
|
Bibliometrics | 1 | 2019 | 339 | 0.030 |
Why?
|
Prostaglandins F | 1 | 1975 | 81 | 0.030 |
Why?
|
Patient Care Management | 1 | 2018 | 306 | 0.030 |
Why?
|
Contraceptive Devices | 1 | 1974 | 24 | 0.030 |
Why?
|
Research Design | 1 | 2011 | 5986 | 0.030 |
Why?
|
Pathology, Surgical | 1 | 2016 | 155 | 0.030 |
Why?
|
Likelihood Functions | 1 | 2018 | 1005 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2020 | 2971 | 0.030 |
Why?
|
Ligation | 1 | 2015 | 453 | 0.030 |
Why?
|
Myosins | 1 | 2016 | 409 | 0.030 |
Why?
|
Surgicenters | 1 | 2014 | 46 | 0.030 |
Why?
|
Methadone | 1 | 1997 | 306 | 0.030 |
Why?
|
Uterine Contraction | 1 | 1975 | 93 | 0.030 |
Why?
|
Florida | 1 | 2015 | 435 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2011 | 9957 | 0.030 |
Why?
|
Abnormalities, Drug-Induced | 1 | 1997 | 317 | 0.030 |
Why?
|
Area Under Curve | 1 | 2018 | 1655 | 0.030 |
Why?
|
Models, Biological | 1 | 2010 | 9584 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2019 | 1364 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 2015 | 667 | 0.030 |
Why?
|
Prostaglandins | 1 | 1974 | 405 | 0.030 |
Why?
|
Life Expectancy | 1 | 2020 | 1184 | 0.030 |
Why?
|
Perioperative Period | 1 | 2014 | 256 | 0.030 |
Why?
|
Motivation | 1 | 2023 | 1971 | 0.030 |
Why?
|
Travel | 1 | 2019 | 788 | 0.030 |
Why?
|
Ohio | 1 | 2013 | 337 | 0.030 |
Why?
|
Health Plan Implementation | 1 | 2016 | 352 | 0.030 |
Why?
|
Europe | 1 | 2019 | 3339 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2019 | 13695 | 0.030 |
Why?
|
Tuberculosis | 1 | 2005 | 1912 | 0.030 |
Why?
|
Ear Neoplasms | 2 | 1992 | 117 | 0.030 |
Why?
|
Length of Stay | 2 | 2019 | 6311 | 0.030 |
Why?
|
Multiple Endocrine Neoplasia Type 2a | 1 | 2011 | 44 | 0.030 |
Why?
|
Observer Variation | 1 | 2018 | 2593 | 0.030 |
Why?
|
Body Temperature | 1 | 2015 | 777 | 0.030 |
Why?
|
Socioeconomic Factors | 2 | 2016 | 7785 | 0.030 |
Why?
|
Hearing Loss | 1 | 2019 | 765 | 0.030 |
Why?
|
Atrophy | 1 | 2016 | 1584 | 0.020 |
Why?
|
Expert Testimony | 1 | 2014 | 356 | 0.020 |
Why?
|
Ear Canal | 1 | 1992 | 146 | 0.020 |
Why?
|
Lymphatic Diseases | 1 | 2013 | 323 | 0.020 |
Why?
|
Hypothermia, Induced | 1 | 2016 | 752 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2023 | 4561 | 0.020 |
Why?
|
Insurance, Health | 1 | 2023 | 2494 | 0.020 |
Why?
|
Demography | 1 | 2015 | 1656 | 0.020 |
Why?
|
Cell Nucleus Size | 1 | 2010 | 11 | 0.020 |
Why?
|
Polyps | 1 | 1992 | 189 | 0.020 |
Why?
|
Cell Nucleus Shape | 1 | 2010 | 16 | 0.020 |
Why?
|
Carcinoembryonic Antigen | 1 | 2011 | 349 | 0.020 |
Why?
|
Weight Gain | 1 | 2020 | 2293 | 0.020 |
Why?
|
Hypopharynx | 1 | 2010 | 52 | 0.020 |
Why?
|
Seroma | 1 | 2010 | 71 | 0.020 |
Why?
|
Philosophy, Medical | 1 | 2010 | 79 | 0.020 |
Why?
|
Anesthesia, General | 1 | 2017 | 1171 | 0.020 |
Why?
|
Intraoperative Period | 1 | 2010 | 520 | 0.020 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2013 | 664 | 0.020 |
Why?
|
Cell Nucleolus | 1 | 2010 | 166 | 0.020 |
Why?
|
Nervous System | 1 | 2013 | 554 | 0.020 |
Why?
|
Overweight | 1 | 2020 | 2371 | 0.020 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2011 | 241 | 0.020 |
Why?
|
Fetus | 1 | 1997 | 1880 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2022 | 2213 | 0.020 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 1991 | 234 | 0.020 |
Why?
|
Sex Distribution | 1 | 2014 | 2297 | 0.020 |
Why?
|
Nasal Cavity | 1 | 1991 | 313 | 0.020 |
Why?
|
Nose Neoplasms | 1 | 1991 | 246 | 0.020 |
Why?
|
Cell Shape | 1 | 2010 | 375 | 0.020 |
Why?
|
Technology Assessment, Biomedical | 1 | 2010 | 306 | 0.020 |
Why?
|
Regression Analysis | 1 | 2018 | 6459 | 0.020 |
Why?
|
Cell Size | 1 | 2010 | 643 | 0.020 |
Why?
|
Developing Countries | 1 | 2020 | 2815 | 0.020 |
Why?
|
Pharynx | 1 | 2010 | 413 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 2008 | 220 | 0.020 |
Why?
|
Kidney Failure, Chronic | 1 | 2019 | 2535 | 0.020 |
Why?
|
Standard of Care | 1 | 2010 | 564 | 0.020 |
Why?
|
International Cooperation | 1 | 2013 | 1420 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2014 | 1504 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2016 | 10943 | 0.020 |
Why?
|
Quinazolines | 1 | 2013 | 1356 | 0.020 |
Why?
|
Research | 1 | 2015 | 1999 | 0.020 |
Why?
|
Health Expenditures | 1 | 2019 | 2349 | 0.020 |
Why?
|
False Negative Reactions | 1 | 2007 | 588 | 0.020 |
Why?
|
Cell Count | 1 | 2010 | 1856 | 0.020 |
Why?
|
History, 20th Century | 1 | 2013 | 2740 | 0.020 |
Why?
|
Hyperplasia | 1 | 2008 | 1185 | 0.020 |
Why?
|
Radiotherapy | 1 | 2012 | 1533 | 0.020 |
Why?
|
Muscle Denervation | 1 | 2004 | 57 | 0.020 |
Why?
|
Mesothelioma | 1 | 1991 | 818 | 0.020 |
Why?
|
Sound Spectrography | 1 | 2004 | 117 | 0.020 |
Why?
|
Phenotype | 1 | 2021 | 16367 | 0.010 |
Why?
|
Functional Laterality | 1 | 2010 | 2290 | 0.010 |
Why?
|
Speech Acoustics | 1 | 2004 | 151 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2012 | 3480 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2010 | 2373 | 0.010 |
Why?
|
Communication | 1 | 2017 | 3750 | 0.010 |
Why?
|
Time Factors | 3 | 2014 | 40077 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1999 | 4034 | 0.010 |
Why?
|
Age Factors | 2 | 2016 | 18373 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2015 | 3229 | 0.010 |
Why?
|
Internet | 1 | 2014 | 3064 | 0.010 |
Why?
|
Linear Models | 1 | 2011 | 5952 | 0.010 |
Why?
|
Oxytocin | 2 | 1975 | 394 | 0.010 |
Why?
|
Caregivers | 1 | 2012 | 2095 | 0.010 |
Why?
|
Progesterone | 2 | 1975 | 775 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2010 | 2638 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2010 | 2727 | 0.010 |
Why?
|
Heart Rate | 1 | 2010 | 4091 | 0.010 |
Why?
|
Nerve Regeneration | 1 | 2004 | 788 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2011 | 12244 | 0.010 |
Why?
|
Logistic Models | 1 | 2011 | 13409 | 0.010 |
Why?
|
Hospitalization | 1 | 2016 | 10259 | 0.010 |
Why?
|
Suppositories | 1 | 1974 | 15 | 0.010 |
Why?
|
Stimulation, Chemical | 1 | 1974 | 326 | 0.010 |
Why?
|
Maternal-Fetal Exchange | 1 | 1997 | 456 | 0.010 |
Why?
|
Pregnancy Trimester, Third | 1 | 1997 | 571 | 0.010 |
Why?
|
Melanoma | 1 | 1992 | 5511 | 0.010 |
Why?
|
Infant, Newborn | 2 | 2007 | 25628 | 0.010 |
Why?
|
Pregnancy Trimester, Second | 1 | 1975 | 732 | 0.010 |
Why?
|
Nausea | 1 | 1974 | 674 | 0.010 |
Why?
|
Vomiting | 1 | 1974 | 637 | 0.010 |
Why?
|
Parity | 1 | 1974 | 929 | 0.010 |
Why?
|
Pressure | 1 | 1974 | 1203 | 0.010 |
Why?
|
Cervix Uteri | 1 | 1975 | 590 | 0.010 |
Why?
|
Uterus | 1 | 1974 | 711 | 0.010 |
Why?
|
Pregnancy | 3 | 1997 | 29144 | 0.010 |
Why?
|
Muscle Contraction | 1 | 1974 | 1235 | 0.010 |
Why?
|
Catheterization | 1 | 1975 | 1470 | 0.010 |
Why?
|
Exercise Test | 1 | 1997 | 2073 | 0.010 |
Why?
|
Skull Neoplasms | 1 | 1969 | 173 | 0.010 |
Why?
|
Fever | 1 | 1974 | 1616 | 0.000 |
Why?
|
Pregnancy Outcome | 1 | 1997 | 2795 | 0.000 |
Why?
|
Temporal Bone | 1 | 1969 | 661 | 0.000 |
Why?
|
Placenta | 1 | 1974 | 1699 | 0.000 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 1969 | 1381 | 0.000 |
Why?
|
Case-Control Studies | 1 | 1997 | 21747 | 0.000 |
Why?
|
Vestibulocochlear Nerve | 1 | 1969 | 116 | 0.000 |
Why?
|
Vestibular Nerve | 1 | 1969 | 101 | 0.000 |
Why?
|
Audiometry | 1 | 1969 | 241 | 0.000 |
Why?
|
Cochlear Nerve | 1 | 1969 | 197 | 0.000 |
Why?
|